Goetzl, Laura (2010) Adverse pregnancy outcomes after abnormal first-trimester screening for aneuploidy. Clin Lab Med 30:613-28
|
Bahado-Singh, Ray O; Wapner, Ronald; Thom, Elizabeth et al. (2005) Elevated first-trimester nuchal translucency increases the risk of congenital heart defects. Am J Obstet Gynecol 192:1357-61
|
Silver, Richard K; Wilson, R Douglas; Philip, John et al. (2005) Late first-trimester placental disruption and subsequent gestational hypertension/preeclampsia. Obstet Gynecol 105:587-92
|
Philip, J; Silver, R K; Wilson, R D et al. (2005) [Late first-trimester invasive prenatal diagnosis--secondary publication. An international randomized trial] Ugeskr Laeger 167:1293-6
|
Wapner, Ronald J (2005) First trimester screening: the BUN study. Semin Perinatol 29:236-9
|
Goetzl, Laura; Krantz, David; Simpson, Joe Leigh et al. (2004) Pregnancy-associated plasma protein A, free beta-hCG, nuchal translucency, and risk of pregnancy loss. Obstet Gynecol 104:30-6
|
Philip, J; Silver, R K; Wilson, R D et al. (2004) Late first-trimester invasive prenatal diagnosis: results of an international randomized trial. Obstet Gynecol 103:1164-73
|
Platt, Lawrence D; Greene, Naomi; Johnson, Anthony et al. (2004) Sequential pathways of testing after first-trimester screening for trisomy 21. Obstet Gynecol 104:661-6
|
Krantz, David; Goetzl, Laura; Simpson, Joe Leigh et al. (2004) Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Am J Obstet Gynecol 191:1452-8
|
Wapner, Ronald; Thom, Elizabeth; Simpson, Joe Leigh et al. (2003) First-trimester screening for trisomies 21 and 18. N Engl J Med 349:1405-13
|